Ran GTPase: A Key Player in Tumor Progression and Metastasis

by Zied Boudhraa, Zied Boudhraa, Euridice Carmona, Euridice Carmona, Diane Provencher, Diane Provencher, Diane Provencher, Anne-Marie Mes-Masson, Anne-Marie Mes-Masson, Anne-Marie Mes-Masson
Published 2020-05-01

Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.

by Julie Lafontaine, Francis Rodier, Véronique Ouellet, Anne-Marie Mes-Masson
Published 2012-01-01

Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies

by Cécile Le Page, David G. Huntsman, Diane M. Provencher, Anne-Marie Mes-Masson
Published 2010-05-01

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion

by Kossay Zaoui, Zied Boudhraa, Paul Khalifé, Euridice Carmona, Diane Provencher, Anne-Marie Mes-Masson
Published 2019-06-01

A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma

by Cécile Le Page, Martin Köbel, Liliane Meunier, Diane M Provencher, Anne‐Marie Mes‐Masson, Kurosh Rahimi
Published 2019-07-01

Candidate Markers of Olaparib Response from Genomic Data Analyses of Human Cancer Cell Lines

by Setor Amuzu, Euridice Carmona, Anne-Marie Mes-Masson, Celia M. T. Greenwood, Patricia N. Tonin, Ioannis Ragoussis
Published 2021-03-01

Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality

by Sylvie Clairefond, Véronique Ouellet, Benjamin Péant, Véronique Barrès, Pierre I. Karakiewicz, Anne-Marie Mes-Masson, Fred Saad
Published 2021-04-01

A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis

by Laudine Communal, Noemi Roy, Maxime Cahuzac, Kurosh Rahimi, Martin Köbel, Diane M. Provencher, Anne-Marie Mes-Masson
Published 2021-05-01

Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.

by Paule Héléna Yoffou, Lydia Edjekouane, Liliane Meunier, André Tremblay, Diane Michèle Provencher, Anne-Marie Mes-Masson, Euridice Carmona
Published 2011-01-01

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls

by Supriya Behl, Nancy Hamel, Manon de Ladurantaye, Stéphanie Lepage, Réjean Lapointe, Anne-Marie Mes-Masson, William D. Foulkes
Published 2020-04-01

Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo models

by Melica Nourmoussavi Brodeur, Kayla Simeone, Kim Leclerc-Deslauniers, Hubert Fleury, Euridice Carmona, Diane M. Provencher, Anne-Marie Mes-Masson
Published 2021-09-01

PUMA and NOXA Expression in Tumor-Associated Benign Prostatic Epithelial Cells Are Predictive of Prostate Cancer Biochemical Recurrence

by Sylvie Clairefond, Benjamin Péant, Véronique Ouellet, Véronique Barrès, Zhe Tian, Dominique Trudel, Pierre I. Karakiewicz, Anne-Marie Mes-Masson, Fred Saad
Published 2020-10-01

Stimulation of Wnt/ß-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young/memory phenotype.

by Marie-Andrée Forget, Yannick Huon, Alexandre Reuben, Cécile Grange, Moïshe Liberman, Jocelyne Martin, Anne-Marie Mes-Masson, Nathalie Arbour, Réjean Lapointe
Published 2012-01-01

Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems.

by Bishnubrata Patra, Muhammad Abdul Lateef, Melica Nourmoussavi Brodeur, Hubert Fleury, Euridice Carmona, Benjamin Péant, Diane Provencher, Anne-Marie Mes-Masson, Thomas Gervais
Published 2020-01-01

Modulation of de Novo Lipogenesis<i> </i>Improves Response to Enzalutamide Treatment in Prostate Cancer

by Mohamed Amine Lounis, Benjamin Péant, Kim Leclerc-Desaulniers, Dwaipayan Ganguli, Caroline Daneault, Matthieu Ruiz, Amina Zoubeidi, Anne-Marie Mes-Masson, Fred Saad
Published 2020-11-01

RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.

by Katia Y Cáceres-Gorriti, Euridice Carmona, Véronique Barrès, Kurosh Rahimi, Isabelle J Létourneau, Patricia N Tonin, Diane Provencher, Anne-Marie Mes-Masson
Published 2014-01-01

Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion

by Matthew G. Annis, Veronique Ouellet, Jonathan P. Rennhack, Sylvain L’Esperance, Claudine Rancourt, Anne-Marie Mes-Masson, Eran R. Andrechek, Peter M. Siegel
Published 2018-01-01

Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification

by Anne Monette, Derek Bergeron, Amira Ben Amor, Liliane Meunier, Christine Caron, Anne-Marie Mes-Masson, Nidhameddine Kchir, Kamel Hamzaoui, Igor Jurisica, Réjean Lapointe
Published 2019-03-01

Proteomic profiling of a mouse model for ovarian granulosa cell tumor identifies VCP as a highly sensitive serum tumor marker in several human cancers.

by Marie-Noëlle Laguë, Raphaëlle Romieu-Mourez, Éric Bonneil, Alexandre Boyer, Nicolas Pouletty, Anne-Marie Mes-Masson, Pierre Thibault, Marie-Ève Nadeau, Derek Boerboom
Published 2012-01-01

Microdissected Tissue vs Tissue Slices—A Comparative Study of Tumor Explant Models Cultured On-Chip and Off-Chip

by Dina Dorrigiv, Kayla Simeone, Laudine Communal, Jennifer Kendall-Dupont, Amélie St-Georges-Robillard, Benjamin Péant, Euridice Carmona, Anne-Marie Mes-Masson, Thomas Gervais
Published 2021-08-01